Literature DB >> 19955281

Putative link between the virulence-associated fluA gene and fluoroquinolone resistance in uropathogenic Escherichia coli.

Petra Lüthje, Annelie Brauner.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955281      PMCID: PMC2815620          DOI: 10.1128/JCM.01443-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  10 in total

1.  Rapid and simple determination of the Escherichia coli phylogenetic group.

Authors:  O Clermont; S Bonacorsi; E Bingen
Journal:  Appl Environ Microbiol       Date:  2000-10       Impact factor: 4.792

2.  Quinolone, fluoroquinolone and trimethoprim/sulfamethoxazole resistance in relation to virulence determinants and phylogenetic background among uropathogenic Escherichia coli.

Authors:  Eva Moreno; Guillem Prats; Montserrat Sabaté; Teresa Pérez; James R Johnson; Antonia Andreu
Journal:  J Antimicrob Chemother       Date:  2006-01-03       Impact factor: 5.790

3.  Three-decade epidemiological analysis of Escherichia coli O15:K52:H1.

Authors:  Bente Olesen; Flemming Scheutz; Megan Menard; Marianne N Skov; Hans Jørn Kolmos; Michael A Kuskowski; James R Johnson
Journal:  J Clin Microbiol       Date:  2009-04-01       Impact factor: 5.948

4.  Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations.

Authors:  H Wang; J L Dzink-Fox; M Chen; S B Levy
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

5.  Decreased prevalence of virulence factors among ciprofloxacin-resistant uropathogenic Escherichia coli isolates.

Authors:  S J Drews; S M Poutanen; T Mazzulli; A J McGeer; A Sarabia; S Pong-Porter; Y Rzayev; B Willey; K Green; D E Low
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts.

Authors:  Juan P Horcajada; Sara Soto; Abby Gajewski; Alex Smithson; M Teresa Jiménez de Anta; Josep Mensa; Jordi Vila; James R Johnson
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

7.  Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans.

Authors:  James R Johnson; Michael A Kuskowski; Krista Owens; Abby Gajewski; Patricia L Winokur
Journal:  J Infect Dis       Date:  2003-08-15       Impact factor: 5.226

8.  Genetic profiles of fluoroquinolone-resistant Escherichia coli isolates obtained from patients with cystitis: phylogeny, virulence factors, PAIusp subtypes, and mutation patterns.

Authors:  Akira Takahashi; Tetsuro Muratani; Mitsuru Yasuda; Satoshi Takahashi; Koichi Monden; Kiyohito Ishikawa; Hiroshi Kiyota; Soichi Arakawa; Tetsuro Matsumoto; Hiroki Shima; Hisao Kurazono; Shingo Yamamoto
Journal:  J Clin Microbiol       Date:  2009-01-21       Impact factor: 5.948

9.  Functional analysis of antigen 43 in uropathogenic Escherichia coli reveals a role in long-term persistence in the urinary tract.

Authors:  Glen C Ulett; Jaione Valle; Christophe Beloin; Orla Sherlock; Jean-Marc Ghigo; Mark A Schembri
Journal:  Infect Immun       Date:  2007-04-09       Impact factor: 3.441

10.  Virulence factors in urinary Escherichia coli strains: phylogenetic background and quinolone and fluoroquinolone resistance.

Authors:  Gabriella Piatti; Alessandro Mannini; Maria Balistreri; Anna Maria Schito
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

  10 in total
  1 in total

1.  Characterisation of uropathogenic Escherichia coli from children with urinary tract infection in different countries.

Authors:  N L Ramos; D T N Dzung; K Stopsack; V Jankó; M R Pourshafie; M Katouli; A Brauner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-21       Impact factor: 3.267

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.